Ozempic / GLP-1 Lawsuits Statistics in Indianapolis
~887,000
City Population
~2.1 million
Metro Population
2 years from discovery (10-year repose)
IN SOL
Eli Lilly (Indianapolis)
Defendant HQ
Courts in Indianapolis, Indiana
Marion County Superior Court
200 E Washington St, Indianapolis, IN 46204
U.S. District Court, Southern District of Indiana
46 E Ohio St, Indianapolis, IN 46204
Hospitals & Trauma Centers in Indianapolis
IU Health Methodist Hospital — Gastroenterology
1701 N Senate Blvd, Indianapolis, IN 46202
Eskenazi Health
720 Eskenazi Ave, Indianapolis, IN 46202
Liability Considerations in Indianapolis
Ozempic & Mounjaro Litigation in Indianapolis
Indianapolis holds unique significance in GLP-1 litigation as the home of Eli Lilly, manufacturer of Mounjaro and Zepbound. Indiana courts have unquestioned personal jurisdiction over Lilly, making Indianapolis a viable venue for state court filings against the company. However, most federal cases are consolidated in MDL 3094 (E.D. Pennsylvania). Indianapolis claimants who used Mounjaro or Zepbound and developed gastroparesis, bowel obstruction, or pancreatitis should consider whether Indiana state court or MDL participation is the better strategic choice — consult experienced plaintiffs' counsel for venue analysis.